These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18205884

  • 1. Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product.
    Sabroe TP, Sabers A.
    Acta Neurol Scand; 2008 Jun; 117(6):428-31. PubMed ID: 18205884
    [Abstract] [Full Text] [Related]

  • 2. Comment on 'Progressive anticonvulsant hypersensitivity syndrome associated with change of drug product' by Sabroe and Sabers.
    Fuglsang A, Holte Ø, Madsen S.
    Acta Neurol Scand; 2008 Aug; 118(2):136-7; author reply 138. PubMed ID: 18518862
    [No Abstract] [Full Text] [Related]

  • 3. [Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome].
    Taillia H, Alla P, Fournier B, Bounolleau P, Ouologem M, Ricard D, Sallansonnet-Froment M, de Greslan T, Renard JL.
    Rev Neurol (Paris); 2009 Oct; 165(10):821-7. PubMed ID: 19362726
    [Abstract] [Full Text] [Related]

  • 4. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG, McCormick J.
    Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
    [Abstract] [Full Text] [Related]

  • 5. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.
    Chang CC, Shiah IS, Yeh CB, Wang TS, Chang HA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):741-4. PubMed ID: 16442685
    [Abstract] [Full Text] [Related]

  • 6. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC, Le L, Ramsey SD, Solow BK, Zakharyan A, Stockl KM, Harada AS, Curtis B.
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [Abstract] [Full Text] [Related]

  • 7. Anticonvulsant hypersensitivity syndrome from addition of lamotrigine to divalproex.
    Rahman M, Haider N.
    Am J Psychiatry; 2005 May; 162(5):1021. PubMed ID: 15863816
    [No Abstract] [Full Text] [Related]

  • 8. Lamotrigine-associated anticonvulsant hypersensitivity syndrome.
    Schlienger RG, Knowles SR, Shear NH.
    Neurology; 1998 Oct; 51(4):1172-5. PubMed ID: 9781550
    [Abstract] [Full Text] [Related]

  • 9. Lamotrigine-induced anticonvulsant hypersensitivity syndrome associated with acute respiratory distress syndrome.
    Deshmukh P, Dao H, Parrisbalogun S, Locala JA.
    Psychosomatics; 2011 Oct; 52(5):495-7. PubMed ID: 21907078
    [No Abstract] [Full Text] [Related]

  • 10. Lamotrigine-induced lupus-like syndrome: a case report and literature review.
    Chang RS, Cole AJ.
    Am J Ther; 2014 Oct; 21(3):e85-7. PubMed ID: 23011169
    [Abstract] [Full Text] [Related]

  • 11. Anticonvulsant hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro.
    Karande S, Gogtay NJ, Kanchan S, Kshirsagar NA.
    Indian J Med Sci; 2006 Feb; 60(2):59-63. PubMed ID: 16505575
    [Abstract] [Full Text] [Related]

  • 12. Lamotrigine rash--a potentially life-threatening complication.
    Hussain N, Gosalakkal JA.
    Emerg Med J; 2007 Jun; 24(6):448. PubMed ID: 17513556
    [No Abstract] [Full Text] [Related]

  • 13. Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy.
    Parri N, Bernardini R, Pucci N, Novembre E, Azzari C, Vierucci A.
    Int J Immunopathol Pharmacol; 2007 Jun; 20(3):643-5. PubMed ID: 17880778
    [No Abstract] [Full Text] [Related]

  • 14. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    LeLorier J, Duh MS, Paradis PE, Lefebvre P, Weiner J, Manjunath R, Sheehy O.
    Neurology; 2008 May 27; 70(22 Pt 2):2179-86. PubMed ID: 18505997
    [Abstract] [Full Text] [Related]

  • 15. [Anticonvulsant hypersensitivity syndrome. 2 case reports and an overview].
    Ronsdorf A, Schlienger RG, Haefeli WE, Martin-Facklam M, Schoenenberger RA.
    Praxis (Bern 1994); 1999 Oct 07; 88(41):1660-6. PubMed ID: 10546511
    [Abstract] [Full Text] [Related]

  • 16. Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.
    Hartung DM, Middleton L, Svoboda L, McGregor JC.
    CNS Drugs; 2012 Aug 01; 26(8):707-16. PubMed ID: 22731934
    [Abstract] [Full Text] [Related]

  • 17. Prolonged anticonvulsant hypersensitivity syndrome related to lamotrigine in a patient with human immunodeficiency virus.
    Beller TC, Boyce JA.
    Allergy Asthma Proc; 2002 Aug 01; 23(6):415-9. PubMed ID: 12528608
    [Abstract] [Full Text] [Related]

  • 18. Lamotrigine in refractory epilepsy: a long-term open study.
    Pisani F, Russo M, Trio R, Artesi C, Fazio A, Oteri G, Di Perri R.
    Epilepsy Res Suppl; 1991 Aug 01; 3():187-91. PubMed ID: 1777079
    [No Abstract] [Full Text] [Related]

  • 19. Successful re-introduction of lamotrigine after initial rash.
    Besag FM, Ng GY, Pool F.
    Seizure; 2000 Jun 01; 9(4):282-6. PubMed ID: 10880290
    [Abstract] [Full Text] [Related]

  • 20. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    Boylan LS.
    Neurology; 2009 May 26; 72(21):1876; author reply 1876-7. PubMed ID: 19470974
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.